spacer
home > > spring 2002 > editor's letter
PUBLICATIONS


Editor's Letter

In 1988 I edited the very first edition of the Technomark Register. At that time we decided to generate two volumes - one for the UK and Ireland and the other for what we chose to call internally 'the rest of Europe'. We set ourselves the objective of including a minimum of 100 CROs as we felt that there was that number of companies in each of the territories. And what a struggle it was. In the end we hit target for the UK, although looking back we did bend the rules a bit by including a few 'one man bands' to make up numbers. A few months later we managed to achieve the same objective for the European volume. I did not calculate the total annual revenue for the companies at that time, but I would be surprised if the total for the whole of Europe was in excess of US$400 million, with a similar figure for North America - effectively at that time 'the rest of the world'. In the 14 years since the first

publication, the market has grown 20-fold to a figure that we estimate to be US$8 billion.
This figure is calculated from the figures reported in the latest editions of the Technomark Register that we have recently published. No longer do we struggle to find 100 companies, no longer do we bend the inclusion rules to make up the numbers. No, we include over 1,500 companies in 40 countries in a mammoth series of volumes that weigh in at over 10kg and occupy 30cm on my bookshelf. (For a detailed discussion of the global CRO market see the article by Marianne O'Neill and myself). It is of constant wonder to me that a market of this sort of scale and scope is as little known and researched as the CRO market. EPC is one of a handful of publications that concentrate exclusively on the CRO scene while books and market research reports are very few and far between. That a market of vital importance to the pharmaceutical industry receives so little attention remains a mystery to me - thank goodness for EPC!


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Graham Hughes
spacer
Dr Graham Hughes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics receives Queen’s Award for Enterprise

Cambridge, UK, 21 April 2020: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has be honored with a Queen’s Award for Enterprise for Innovation. The award recognizes the Company’s excellence in patenting, developing and globally commercializing single cell analysis systems for biotherapeutic discovery.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement